Global Premature Ejaculation Treatment Market 2016-2020

Price :
Published : Aug-2016
No. of Pages : 57

Premature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient’s relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes.

The analyst forecast global premature ejaculation treatment market to grow at a CAGR of 9.65% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of premature ejaculation drugs and premature ejaculation solutions.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report Global Premature Ejaculation Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Absorption Pharmaceuticals
  • Allergan
  • Innovus Pharmaceuticals
  • Plethora

Other prominent vendors

  • Aytu BioScience
  • Bayer
  • Dong-A Pharmaceutical
  • Eli Lilly
  • Emcure
  • Futura Medical
  • GlaxoSmithKline
  • NeuroHealing Pharmaceuticals
  • Pfizer

Market driver

  • Rise in number of erectile dysfunction cases
  • For a full, detailed list, view our report

Market challenge

  • Threat of alternative treatments
  • For a full, detailed list, view our report

Market trend

  • Increase in awareness of premature ejaculation
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Spectrum Pharmaceuticals Inc (SPPI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company's marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection); Zevalin (ibritumomab tiuxetan); Marqibo (vincristine sulfate liposome injection), Beleodaq (belinostat) and Evomela (Captisol-Enabled Melphalan). It also has drugs in mid-to-late stage development, namely, Rolontis (eflapegrastim) for chemotherapy-induced neutropenia; Qapzola (apaziquone) for Intravesical Instillation; and Poziotinib for the treatment of various types of cancers. The company markets its products through direct sales force in the US and through distributors in Europe. Spectr......

Goodwin Biotechnology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic filling and finishing, and cGMP manufacturing services. It also offers a range of mammalian cell culture development and manufacturing services. The company's support services comprise assay development, quality control, quality assurance, regulatory support and translational medicine and consulting services. It caters to various academic institutions, government agencies, biopharmaceutical companies and other sectors across the US. GBI is headquartered in Plantation, Florida, the US. Goo......

Karus Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Karus Therapeutics Ltd (Karus) is a designer and developer of molecule cancer therapies. The company provides treatment of a diverse range of solid and hematological cancers and small molecule drug. It develops two clinic-tracked programs potent and selective inhibitors of PI3K and HDAC for the treatment of inflammatory disease. Karus develops and markets medicines based on the potent and isoform-selective inhibition of two enzyme families such as histone deacetylase and PI3 kinase. The company's development programs offer medical needs in the fields of chronic inflammation, retaining drug design, immunotherapeutic modes, haematological malignancies and solid tumours. Its HDAC6 inhibitors are anti-tumour agents for the treatment of multiple myeloma. Karus is headquartered in Oxf......

KBI Biopharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization's service portfolio includes process development and cGMP manufacturing of recombinant protein active pharmaceutical ingredients, protein characterization, formulation, process design and development and testing. KBI also offers technology transfer, modeling and simulation and release testing and stability programs. The organization caters to clients worldwide to accelerate and optimize their drug development programs. It has offices in Durham, Boulder and The Woodlands. KBI is headquartered in Durham, North Carolina, the US. KBI Biopharma Inc - Pharmaceuticals & Hea......

Epic Pharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug company that develops and manufactures generic prescription drugs. The company's products include citalopram, betaxolol, amlodipine besylate, meperidine hydrochloride, flacoxate hydrochloride, nicardipine hydrochloride, guanfacine hydrochloride, sulindac, and ursodiol. It also offers contract manufacturing, encapsulation, tableting, packaging and testing services. Epic Pharma offers products in dosage forms of powder, capsule and tablet forms. It markets its products through its network of distributors. The company operates through manufacturing facility located in the US. Epic Pharma is headquartered in Laurelton, New York, the US. Epic Pharma LLC - Pharmaceuticals & Healthcare - Dea......

Nonlinear Dynamics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Nonlinear Dynamics Ltd (Nonlinear Dynamics), a subsidiary of Waters Corp is a data analysis software development company that provides analysis software products. The company offers products such as Progenesis CoMet that analyses LC-MS and GC-MS data to discover and quantify compounds. It research and develops proteomics analysis software, gel and data analysis software. Nonlinear Dynamics provides Progenesis LC MS, a data analysis program that enables to find and quantify the proteins. The company's products are used as application software that offers proteomics data for biomarker discovery using MALDI-TOF and SELDI analysis. Nonlinear Dynamics is headquartered in Newcastle upon Tyne, the UK. Nonlinear Dynamics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profil......

LegoChem Biosciences Inc (141080) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary LegoChem Biosciences Inc (LCB) is a drug company that research and develops small molecule drugs. The company's services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services include metabolic stability, plasma stability, protein binding, and cell toxicity. LCB also offers compound synthesis and process development services. The company manufactures drugs in the therapeutic areas of antibiotics, anticoagulants, anticancer and anti-inflammation. It conducts research programs through co-developments, joint researches, and global pharmaceutical companies. The company serves in different parts of Korea. LCB is headquartered in Daejeon, South Korea. LegoChem Biosciences Inc (141080) - Pharmaceuti......

ATUM – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ATUM, formerly DNA2.0 Inc is a bioengineering company that provide platforms for protein and vector engineering solutions. The company develops and offers synthetic biology solutions. Its products include expression vectors, electra system, CRISPR/Cas9, proteinpaintbox, cell strains and reagents. ATUM offers services such as gene synthesis, protein engineering, expression optimization, and vector engineering. The company provides antibody to developing enzymes for commercial drug and biofuel manufacture. It provides synthetic biology tools that include gene designer, GRNA designer, DNA atlas, bioinformatic, toolbox and literature database. The company serves academic, government and the pharmaceutical, chemical, agricultural and biotechnology industries. It operates through its ......

Foundation Medicine Inc (FMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas and others. It also offers additional materials, services, and real-time data through its technology products. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US. Foundation Medicine Inc (FMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you com......

ImaBiotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that provides mass spectrometry imaging services. The organization offers software products such as multimaging and quantinetix. Its service portfolio includes consulting and training, biomarker discovery, pharmaco-kinetics and dynamics studies, screening studies, target engagement studies, and toxicology studies. ImaBiotech offers MALDI imaging services to therapeutic areas such as cardiovascular and metabolic diseases, central nervous system, dermatology and cosmetics, gastroenterology, and others. The organization provides consultancy and training services such as feasibility or protocol studies, cost and profitability; data storage, MALDI imaging mass spectrometry platform installation, project design, instrumen......